Efficacy and durability of radiofrequency ablation for barrett's esophagus: Systematic review and meta-analysis

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 10, 2013, Pages 1245-1255

  Orman, Eric S ^a   Li, Nan ^a   Shaheen, Nicholas J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Endoscopy; Esophageal Cancer; Gastroesophageal Reflux; Prevention

Indexed keywords

ADVERSE OUTCOME; BARRETT ESOPHAGUS; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; DISEASE COURSE; ESOPHAGUS CANCER; ESOPHAGUS DYSPLASIA; ESOPHAGUS STENOSIS; HUMAN; INTESTINE METAPLASIA; META ANALYSIS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ABLATION OF INTESTINAL METAPLASIA; AIM; BARRETT'S ESOPHAGUS; BE; CE-D; CE-IM; CI; COMPLETE ERADICATION OF DYSPLASIA; COMPLETE ERADICATION OF INTESTINAL METAPLASIA; CONFIDENCE INTERVAL; EAC; EMR; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL CANCER; GASTROESOPHAGEAL REFLUX; HGD; HIGH-GRADE DYSPLASIA; IM; IMC; INTESTINAL METAPLASIA; INTRAMUCOSAL CARCINOMA; LGD; LOW-GRADE DYSPLASIA; NDBE; NONDYSPLASTIC BARRETT'S ESOPHAGUS; PREVENTION; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL; RCT; RFA; RISK RATIO; RR;

BARRETT ESOPHAGUS; CATHETER ABLATION; HUMANS; RECURRENCE; TREATMENT OUTCOME;

EID: 84884357436     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.03.039     Document Type: Review

References (41)

1. Spechler S.J., Sharma P., Souza R.F., et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011, 140:1084-1091.
2. Ronkainen J., Aro P., Storskrubb T., et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 2005, 129:1825-1831.
3. Hvid-Jensen F., Pedersen L., Drewes A.M., et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. NEngl J Med 2011, 365:1375-1383.
4. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007, 65:185-195.
5. Overholt B.F., Panjehpour M., Haydek J.M. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999, 49:1-7.
6. Shaheen N.J., Greenwald B.D., Peery A.F., et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 2010, 71:680-685.
7. Basu K.K., Pick B., Bale R., et al. Efficacy and one year follow up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 2002, 51:776-780.
8. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. NEngl J Med 2009, 360:2277-2288.
9. Okoro N.I., Tomizawa Y., Dunagan K.T., et al. Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. Clin Gastroenterol Hepatol 2012, 10:150-154.
10. Pouw R.E., Wirths K., Eisendrath P., et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010, 8:23-29.
11. Fleischer D.E., Overholt B.F., Sharma V.K., et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 2010, 42:781-789.
12. Sharma V.K., Jae Kim H., Das A., et al. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol 2009, 104:310-317.
13. Lyday W.D., Corbett F.S., Kuperman D.A., et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 2010, 42:272-278.
14. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
15. Bulsiewicz W.J., Kim H.P., Dellon E.S., et al. Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett's esophagus. Clin Gastroenterol Hepatol 2013, 11:636-642.
16. Orman E.S., Kim H.P., Bulsiewicz W.J., et al. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radiofrequency ablation. Am J Gastroenterol 2013, 108:187-195.
17. Downs S.H., Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. JEpidemiol Community Health 1998, 52:377-384.
18. Wallace B.C., Schmid C.H., Lau J., et al. Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol 2009, 9:80.
19. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
20. Freeman M.F., Tukey J.F. Transformations related to the angular and the square root. Ann Math Stat 1950, 21:607-611.
21. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
22. Fleischer D.E., Overholt B.F., Sharma V.K., et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008, 68:867-876.
23. Velanovich V. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned. Surg Endosc 2009, 23:2175-2180.
24. Shaheen N.J., Overholt B.F., Sampliner R.E., et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011, 141:460-468.
25. van Vilsteren F.G., Pouw R.E., Seewald S., et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011, 60:765-773.
26. Akiyama J., Marcus S.N., Triadafilopoulos G. Effective intra-esophageal acid control is associated with improved radiofrequency ablation outcomes in Barrett's esophagus. Dig Dis Sci 2012, 57:2625-2632.
27. Caillol F., Bories E., Pesenti C., et al. Radiofrequency ablation associated to mucosal resection in the oesophagus: experience in a single centre. Clin Res Hepatol Gastroenterol 2012, 36:371-377.
28. Krishnan K., Pandolfino J.E., Kahrilas P.J., et al. Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology 2012, 143:576-581.
29. Zemlyak A.Y., Pacicco T., Mahmud E.M., et al. Radiofrequency ablation offers a reliable surgical modality for the treatment of Barrett's esophagus with a minimal learning curve. Am Surg 2012, 78:774-778.
30. Haidry R.J., Dunn J.M., Thorpe S., et al. Radio frequency ablation is more effective in shorter segments of Barrett's oesophagus for eradication of high grade dysplasia/intramucosal cancer - results from the UK RFA HALO registry. Gastroenterology 2011, 140:S215.
31. Dulai P.S., Fadden L.L., Gordon S.R., et al. Size really doesn't matter - a single center experience with radiofrequency ablation of ultra long-segment Barrett's esophagus. Gastrointest Endosc 2012, 75:AB451.
32. Gupta M., Lutzke L.S., Wang K.K., et al. Safety and outcomes of radiofrequency ablation for Barrett's esophagus in older subjects: results from a betrnet consortium. Gastrointest Endosc 2012, 75:AB159.
33. Martinek J., Stefanova M., Suchanek S., et al. Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 7 CM. Gastrointest Endosc 2012, 75:AB459-AB460.
34. Shaheen N.J., Bulsiewicz W.J., Rothstein R.I., et al. Eradication rates of Barrett's esophagus using radiofrequency ablation (RFA): results from the U.S. RFA registry. Gastrointest Endosc 2012, 75:AB460.
35. Ganz R.A., Utley D.S., Stern R.A., et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 2004, 60:1002-1010.
36. Sikkema M., Looman C.W., Steyerberg E.W., et al. Predictors for neoplastic progression in patients with Barrett's esophagus: a prospective cohort study. Am J Gastroenterol 2011, 106:1231-1238.
37. Sharma P., Falk G.W., Weston A.P., et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006, 4:566-572.
38. Peters F.P., Brakenhoff K.P., Curvers W.L., et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. Gastrointest Endosc 2008, 67:604-609.
39. Wani S., Puli S.R., Shaheen N.J., et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 2009, 104:502-513.
40. Lewis J.J., Rubenstein J.H., Singal A.G., et al. Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett's esophagus. Gastrointest Endosc 2011, 74:753-760.
41. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005, 62:488-498.